Based on the significant correlation between tryptophan metabolism and glioma development as well as TMZ efficacy (Additional file 1: Fig. S9, S4C and Fig. 4E), we speculate that IDO1 and AHR are the potential targets in bacterial tryptophan metabolism. Here, AHR is linked to central nervous system cancer.